We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
-13.79%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$273M
AUM Growth
-$31M
Cap. Flow
+$3.24M
Cap. Flow %
1.19%
Top 10 Hldgs %
41.92%
Holding
103
New
39
Increased
16
Reduced
16
Closed
28

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$8.47M
2
MDVN
MEDIVATION, INC.
MDVN
+$7.8M
3
MDT icon
Medtronic
MDT
+$7.53M
4
HCA icon
HCA Healthcare
HCA
+$6.98M
5
PFE icon
Pfizer
PFE
+$6.02M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$12.2M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$9.85M
3
AMGN icon
Amgen
AMGN
+$9.66M
4
AET
Aetna Inc
AET
+$5.41M
5
ESRX
Express Scripts Holding Company
ESRX
+$5.25M

Sector Composition

Rank Sector Weight
1 Healthcare 67.79%
2 Industrials 0.39%
3 Consumer Staples 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGTC
51
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.4M 0.51%
100,000
-50,000
-33% -$733K
ITCI
52
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.39M 0.51%
+50,000
New +$1.67M
TNDM icon
53
Tandem Diabetes Care
TNDM
$1.61B
$1.31M 0.48%
+15,000
New +$1.31M
CYTK icon
54
Cytokinetics
CYTK
$10.2B
$1.23M 0.45%
175,000
-175,000
-50% -$1.28M
PETX
55
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.1M 0.4%
+200,000
New +$752K
TNET icon
56
TriNet
TNET
$3.22B
$1.08M 0.39%
+75,000
New +$1.06M
BLUE
57
DELISTED
bluebird bio
BLUE
$1.06M 0.39%
+1,930
New +$1.19M
OMED
58
CALL
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.01M 0.37%
100,000
+50,000
+100% +$587K
SRPT icon
59
CALL
Sarepta Therapeutics
SRPT
$1.95B
$976K 0.36%
+50,000
New +$874K
HTWR
60
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$943K 0.35%
30,000
-40,000
-57% -$1.35M
AERI
61
DELISTED
Aerie Pharmaceuticals
AERI
$912K 0.33%
+75,000
New +$1.19M
PBYI icon
62
Puma Biotechnology
PBYI
$450M
$881K 0.32%
30,000
+5,000
+20% +$226K
RXDX
63
DELISTED
Ignyta, Inc.
RXDX
$846K 0.31%
125,000
-35,000
-22% -$288K
LAB icon
64
Standard BioTools
LAB
$294M
$807K 0.3%
+100,000
New +$721K
CSII
65
DELISTED
Cardiovascular Systems, Inc.
CSII
$778K 0.29%
+75,000
New +$759K
ARIA
66
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$639K 0.23%
100,000
-100,000
-50% -$560K
PACB icon
67
Pacific Biosciences
PACB
$357M
$638K 0.23%
+75,000
New +$738K
EXEL icon
68
Exelixis
EXEL
$12.5B
$600K 0.22%
+150,000
New +$635K
GI
69
DELISTED
EndoChoice Holdings, Inc.
GI
$599K 0.22%
+115,000
New +$631K
FWP
70
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$510K 0.19%
+4,286
New +$480K
SCYX icon
71
SCYNEXIS
SCYX
$50.9M
$504K 0.18%
1,563
– –
SGMO
72
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$454K 0.17%
75,000
-125,000
-63% -$751K
DERM
73
PUT
DELISTED
Dermira, Inc.
DERM
$414K 0.15%
+20,000
New +$491K
AXDX
74
CALL
DELISTED
Accelerate Diagnostics
AXDX
$359K 0.13%
+2,500
New +$353K
ARIA
75
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$320K 0.12%
+50,000
New +$280K
1 2
3
4 5

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q1 2016 Portfolio in Review

As of Q1 2016, Iguana Healthcare Management held 103 positions worth $273M, down 10% from $304M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Iguana Healthcare Management's Q1 2016 filing shows 39 new, 16 increased, 16 reduced and 28 closed positions. Its largest new stake was Zimmer Biomet: 87,550 shares worth $9.06M. The largest sale was Viatris, an estimated $12.2M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 78% a quarter earlier, followed by Industrials and Consumer Staples.

  • Iguana Healthcare Management's largest Q1 2016 buy was Zimmer Biomet: 87,550 shares worth $9.06M.
  • Iguana Healthcare Management added most to MEDIVATION, INC. in Q1 2016, an estimated $7.8M increase.
  • Iguana Healthcare Management's biggest Q1 2016 reduction was Amgen, cutting an estimated $9.66M.
  • Iguana Healthcare Management fully exited Viatris in Q1 2016, selling an estimated $12.2M.
  • Iguana Healthcare Management's ten largest holdings make up 42% of its $273M portfolio in Q1 2016.
  • Iguana Healthcare Management opened 39 new positions and closed 28 in Q1 2016.
  • Iguana Healthcare Management's portfolio value fell 10% quarter-over-quarter to $273M.

Based on Iguana Healthcare Management's 13F filing for Q1 2016, filed 17 May 2016.